ChromaDex

NIH study shows elevating NAD+ with NR supplementation effectively reduces inflammation

Supplements

ChromaDex and Zesty Paws team up on cellular health for dogs

Innovation Supplements

Longevity investment bulletin: XtalPi, Levolta, MetrioPharm and more

Investment Investment

A strong patent portfolio delivers a competitive edge in the longevity space

Investment Investment Supplements Videos

Longevity investment bulletin: ChromaDex, Nightingale Health, Capsida and more

Investment Investment

Longevity investment bulletin: Five Alarm Bio, Capsida, MyMD and more

Investment Investment

ChromaDex and Nestlé announce new Niagen commercial supply agreement and $5m investment

Investment Supplements

ChromaDex shares promising findings from nicotinamide riboside clinical trial

Biotech Investment Supplements

New immune supplement launches with NAD+ boost for optimal maintenance of aging cells

Supplements